Educational content on VJRegenMed is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

Advanced Therapies Week 2022 | The logistics of manufacturing allogeneic therapies on a large scale

Julia Tarasenko, MSc, Marken, Durham, NC, discusses changes that are needed in the supply chain to adapt to an increasing demand in allogeneic therapies. Pivoting to a one-to-many supply chain is crucial to successfully manufacture allogeneic therapies on a larger scale, as well as focusing on local suppliers and storage, especially in the light of the COVID-19 pandemic. She additionally highlights the need to increase biobanking capabilities as the industry shifts to allogeneic therapies. This interview took place at Advanced Therapies Week 2022.


Julia Tarasenko is an employee of Marken.